Chemical modulation of the tumor microenvironment enabled by nanomaterials for enhanced cancer treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment10.1038/aps.2015.92 ↗
3. Tumor Microenvironment-Enabled Nanotherapy10.1002/adhm.201701156 ↗
4. Biomaterials tools to modulate the tumour microenvironment in immunotherapy10.1038/s44222-022-00004-6 ↗
5. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth10.1016/j.ccell.2023.02.016 ↗
6. Tumor microenvironment: recent advances in various cancer treatments
7. Nanoparticles for Cancer Therapy: Current Progress and Challenges10.1186/s11671-021-03628-6 ↗
8. Liposomes for Tumor Targeted Therapy: A Review10.3390/ijms24032643 ↗
9. Polymeric micelles in cancer therapy: State of the art10.1016/j.jconrel.2021.02.016 ↗
10. Targeting drugs to tumours using cell membrane-coated nanoparticles10.1038/s41571-022-00699-x ↗
11. Transformable peptide nanoparticles arrest HER2 signalling and cause cancer cell death in vivo10.1038/s41565-019-0626-4 ↗
12. PROTAC Prodrug-Integrated Nanosensitizer for Potentiating Radiation Therapy of Cancer
13. Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy10.1038/s41467-022-31764-9 ↗
14. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment10.1073/pnas.1406655111 ↗
15. An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression10.1016/j.ccell.2017.10.003 ↗
16. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia10.1186/s13045-021-01102-5 ↗
17. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions10.1038/s41392-023-01332-8 ↗
18. Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy10.1016/j.jconrel.2019.12.028 ↗
19. Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response10.1021/nn405773r ↗
20. Hybrid Manganese Dioxide Nanoparticles Potentiate Radiation Therapy by Modulating Tumor Hypoxia10.1158/0008-5472.CAN-15-3475 ↗
21. Advances in nanomaterials for treatment of hypoxic tumor10.1093/nsr/nwaa160 ↗
22. Synthesis of Copper Peroxide Nanodots for H2O2 Self-Supplying Chemodynamic Therapy10.1021/jacs.9b03457 ↗
23. Ultrasound-Induced Reactive Oxygen Species Mediated Therapy and Imaging Using a Fenton Reaction Activable Polymersome10.1021/acsnano.5b06175 ↗
24. Strategies of Alleviating Tumor Hypoxia and Enhancing Tumor Therapeutic Effect by Macromolecular Nanomaterials10.1002/mabi.202100092 ↗
25. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy10.1038/ncomms9785 ↗
26. Erythrocyte-Membrane-Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy10.1002/adma.201701429 ↗
27. Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies10.1021/acs.nanolett.6b02365 ↗
28. Magnesium silicide nanoparticles as a deoxygenation agent for cancer starvation therapy10.1038/nnano.2016.280 ↗
29. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses10.1038/s41467-017-01050-0 ↗
30. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
31. Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy10.1016/j.biomaterials.2021.121250 ↗
32. Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses10.1038/s41551-018-0262-6 ↗
33. Tumor Microenvironment Modulating CaCO3 -Based Colloidosomal Microreactors Can Generally Reinforce Cancer Immunotherapy
34. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory10.1016/j.actbio.2019.05.009 ↗
35. Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma10.1186/s12951-023-01820-7 ↗
36. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo10.1038/nbt.4071 ↗
37. Polymeric materials for embolic and chemoembolic applications10.1016/j.jconrel.2016.02.033 ↗
38. The impact of regular aspirin use on aneurysm recanalization rates after endovascular coiling10.3171/2024.1.JNS232726 ↗
39. Nanoclustered Cascaded Enzymes for Targeted Tumor Starvation and Deoxygenation-Activated Chemotherapy without Systemic Toxicity10.1021/acsnano.9b02466 ↗
40. The Acidic Tumor Microenvironment as a Driver of Cancer10.1146/annurev-physiol-021119-034627 ↗
41. Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation10.1016/j.semcancer.2017.03.001 ↗
42. Drug resistance and cellular adaptation to tumor acidic pH microenvironment10.1021/mp200292c ↗
43. M2-TAM subsets altered by lactic acid promote T-cell apoptosis through the PD-L1/PD-1 pathway
44. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation10.1002/1521-4141(200109)31:9<2829::AID-IMMU2829>3.0.CO;2-U ↗
45. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
46. The acidic tumor microenvironment: a target for smart cancer nano-theranostics10.1093/nsr/nwx062 ↗
47. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer10.1186/s13046-015-0194-x ↗
48. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer
49. Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial10.1001/jamaoncol.2016.3358 ↗
50. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes10.1158/0008-5472.CAN-11-1272 ↗
51. Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab10.1158/1078-0432.CCR-20-1876 ↗
52. Side Effects of Long-Term Proton Pump Inhibitor Use: A Review10.1111/bcpt.13023 ↗
53. Enhancement of chemotherapy by manipulation of tumour pH10.1038/sj.bjc.6690455 ↗
54. Bicarbonate increases tumor pH and inhibits spontaneous metastases10.1158/0008-5472.CAN-07-5575 ↗
55. Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy10.1158/0008-5472.CAN-15-1743 ↗
56. Effects of Alkalization Therapy on Chemotherapy Outcomes in Metastatic or Recurrent Pancreatic Cancer10.21873/anticanres.14020 ↗
57. A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis10.7554/eLife.15691 ↗
58. Free Base Lysine Increases Survival and Reduces Metastasis in Prostate Cancer Model
59. Reduction of metastasis using a non-volatile buffer10.1007/s10585-011-9415-7 ↗
60. Research progress of calcium carbonate nanomaterials in cancer therapy: challenge and opportunity10.3389/fbioe.2023.1266888 ↗
61. Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo10.1039/C5NR06162H ↗
62. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment10.1038/s41565-018-0319-4 ↗
63. CaCO3 based proton nanosponge to potentiate immune checkpoint blockade therapy by synergistically reversing tumor immunosuppression10.1016/j.cej.2023.142206 ↗
64. Coordination Polymer-Coated CaCO3 Reinforces Radiotherapy by Reprogramming the Immunosuppressive Metabolic Microenvironment
65. CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy10.1007/s40820-020-00549-4 ↗
66. Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
67. Sodium Bicarbonate Nanoparticles for Amplified Cancer Immunotherapy by Inducing Pyroptosis and Regulating Lactic Acid Metabolism10.1002/anie.202307706 ↗
68. A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors
69. Biodegradable Ferrous Sulfide-Based Nanocomposites for Tumor Theranostics through Specific Intratumoral Acidosis-Induced Metabolic Symbiosis Disruption10.1021/jacs.2c07669 ↗
70. Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy10.1002/anie.201710144 ↗
71. Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes10.1096/fj.00-0029com ↗
72. Amorphous Fe-Based Nanoagents for Self-Enhanced Chemodynamic Therapy by Re-Establishing Tumor Acidosis
73. Engineering of Cascade-Responsive Nanoplatform to Inhibit Lactate Efflux for Enhanced Tumor Chemo-Immunotherapy10.1021/acsnano.0c07071 ↗
74. Reactive Oxygen Species in the Tumor Microenvironment: An Overview10.3390/cancers11081191 ↗
75. The multifaceted role of reactive oxygen species in tumorigenesis10.1007/s00018-020-03536-5 ↗
76. Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction10.1002/anie.201510031 ↗
77. Nanocatalyst-Mediated Chemodynamic Tumor Therapy10.1002/adhm.202101971 ↗
78. Strategies for enhancing cancer chemodynamic therapy performance
79. Engineered Bacterial Bioreactor for Tumor Therapy via Fenton-Like Reaction with Localized H2 O2 Generation
80. Tumor-selective catalytic nanomedicine by nanocatalyst delivery10.1038/s41467-017-00424-8 ↗
81. Percutaneous implantation of ethanol fueled catalytic hydrogel suppresses tumor growth by triggering ferroptosis10.1016/j.mattod.2022.03.013 ↗
82. Synthesis of CaCO3-Based Nanomedicine for Enhanced Sonodynamic Therapy via Amplification of Tumor Oxidative Stress10.1016/j.chempr.2020.02.020 ↗
83. Remodeling endogenous H2S microenvironment in colon cancer to enhance chemodynamic therapy10.1016/j.cej.2021.130098 ↗
84. The Natural Diterpenoid Isoforretin A Inhibits Thioredoxin-1 and Triggers Potent ROS-Mediated Antitumor Effects10.1158/0008-5472.CAN-16-0987 ↗
85. Selenium Atom-Polarization Effect Determines TrxR-Specific Recognition of Metallodrugs10.1021/jacs.2c08802 ↗
86. Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses10.1038/s41467-021-24604-9 ↗
87. Engineering bioluminescent bacteria to boost photodynamic therapy and systemic anti-tumor immunity for synergistic cancer treatment10.1016/j.biomaterials.2021.121332 ↗
88. Metallo-alginate hydrogel can potentiate microwave tumor ablation for synergistic cancer treatment10.1126/sciadv.abo5285 ↗
89. Piezocatalytic Tumor Therapy by Ultrasound-Triggered and BaTiO3-Mediated Piezoelectricity10.1002/adma.202001976 ↗
90. Platinum Nanoparticles to Enable Electrodynamic Therapy for Effective Cancer Treatment10.1002/adma.201806803 ↗
91. Magnetostrictive-Piezoelectric-Triggered Nanocatalytic Tumor Therapy10.1021/acs.nanolett.1c01313 ↗
92. Amplifying oxidation stress and T-cell activation by bioactive layered double hydroxide sonosensitizers for enhanced cancer immunotherapy10.1016/j.mattod.2023.06.023 ↗
93. Photocatalysis-mediated drug-free sustainable cancer therapy using nanocatalyst10.1038/s41467-021-21618-1 ↗
94. An anisotropic photocatalytic agent elicits robust photoimmunotherapy through plasmonic catalysis-mediated tumor microenvironment modulation10.1016/j.nantod.2023.101827 ↗
95. A Titanium Nitride Nanozyme for pH-Responsive and Irradiation-Enhanced Cascade-Catalytic Tumor Therapy10.1002/anie.202106750 ↗
96. In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy10.1038/s41467-018-03903-8 ↗
97. A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage10.1016/j.nantod.2023.101798 ↗
98. Recent advances in multi-metallic-based nanozymes for enhanced catalytic cancer therapy
99. Peroxisome inspired hybrid enzyme nanogels for chemodynamic and photodynamic therapy10.1038/s41467-021-25561-z ↗
100. Hypochlorous Acid Promoted Platinum Drug Chemotherapy by Myeloperoxidase-Encapsulated Therapeutic Metal Phenolic Nanoparticles10.1021/acsnano.7b06852 ↗